1.3 billion children immunised, 23 million lives saved
Gavi, the Vaccine Alliance has now helped immunise roughly one-sixth of humanity since our inception in 2000. Read all the latest results in Gavi's 2025 Annual Progress Report.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreCan two new vaccines help turn the tide against Bundibugyo Ebola?
Two experimental Ebola vaccines are set to join a crucial trial in the Democratic Republic of the Congo as the Bundibugyo virus disease outbreak there continues.
What’s a 'Vaccinodrome'? In this rural town in Mali, it’s a life-saver
In Mali’s Sikasso region, community dialogues, home visits and the support of a local imam helped to pave the way for a pragmatic fix for under-immunisation.
Sewers could hold the key to detecting deadly fungal infections
Fungal infections kill millions a year, yet few health systems monitor them. Testing sewage could reveal where drug-resistant fungi are spreading.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
Are you a CSO? We want to hear from you!
As Gavi implements its 6.0 strategy and progresses its Gavi Leap transformation, the Gavi Secretariat is reviewing how civil society participates in its governance and decision-making processes.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allThe Royal Government of Cambodia, through the Ministry of Health and the NIP, today launched a nationwide HPV Multi-Age Cohort (MAC) vaccination campaign, which vaccinates multiple age groups of adolescent girls at the same time, and catch-up…
An agreement announced today will cut the price of the RTS,S/AS01 malaria vaccine by approximately 40 per cent. The deal, executed by UNICEF and financially backed by Gavi, the Vaccine Alliance, is expected to generate around US$ 50 million in…
Vaccines deliver over US$ 30 billion in economic benefits for lower-income countries in 2025
Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.3 billion children – and prevented more than 23 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
